1. Home
  2. RECT vs QNCX Comparison

RECT vs QNCX Comparison

Compare RECT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.30

Market Cap

19.1M

Sector

N/A

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
QNCX
Founded
1997
2012
Country
Singapore
United States
Employees
111
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
19.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RECT
QNCX
Price
$1.30
$1.04
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
13.1K
1.4M
Earning Date
03-20-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.74
$0.38
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.08
52 Week High
$4.98
$4.55

Technical Indicators

Market Signals
Indicator
RECT
QNCX
Relative Strength Index (RSI) 46.96 46.14
Support Level $1.02 $0.79
Resistance Level $1.30 $1.45
Average True Range (ATR) 0.11 0.13
MACD 0.00 -0.03
Stochastic Oscillator 60.97 44.64

Price Performance

Historical Comparison
RECT
QNCX

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: